This inventor holds 5 USPTO granted patents and 4 published patent applications. Top assignee: Tune Therapeutics, Inc.. Active years: 2025.
Company Filing History:
Years Active: 2025
Title: Britta Jones: Innovator in Hepatitis B Research
Introduction
Britta Jones is a prominent inventor based in Durham, NC (US), known for her significant contributions to the field of biotechnology. With a focus on innovative solutions for viral infections, she has developed groundbreaking technologies aimed at combating Hepatitis B.
Latest Patents
Jones holds 5 patents, with her latest work centered on "Compositions, systems, and methods for regulation of Hepatitis B virus through targeted gene repression." This invention involves the use of epigenetic-modifying DNA-targeting systems, such as CRISPR-Cas/guide RNA (gRNA) systems, to transcriptionally repress Hepatitis B viral (HBV) genes. The goal is to promote a cellular phenotype that reduces HBV infection. The systems are designed to bind to specific gene sites within the Hepatitis B viral DNA sequence, thereby repressing viral replication and expression.
Career Highlights
Jones is currently employed at Tune Therapeutics, Inc., where she continues to advance her research in gene regulation and viral therapies. Her work has the potential to significantly impact the treatment of Hepatitis B infections, providing new avenues for therapeutic intervention.
Collaborations
Throughout her career, Jones has collaborated with notable colleagues, including Brian Cosgrove and Kendra Congdon, who contribute to her innovative research efforts.
Conclusion
Britta Jones exemplifies the spirit of innovation in the biotechnology sector, with her patents paving the way for new treatments for Hepatitis B. Her work not only highlights her expertise but also underscores the importance of collaboration in advancing scientific research.